Your browser doesn't support javascript.
loading
Incidence and imaging characteristics of difficult to detect retrospectively identified brain metastases in patients receiving repeat courses of stereotactic radiosurgery.
Fairchild, Andrew; Salama, Joseph K; Godfrey, Devon; Wiggins, Walter F; Ackerson, Bradley G; Oyekunle, Taofik; Niedzwiecki, Donna; Fecci, Peter E; Kirkpatrick, John P; Floyd, Scott R.
Afiliação
  • Fairchild A; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA. ATFairchild@novanthealth.org.
  • Salama JK; Piedmont Radiation Oncology, 3333 Silas Creek Parkway, Winston Salem, NC, 27103, USA. ATFairchild@novanthealth.org.
  • Godfrey D; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.
  • Wiggins WF; Radiation Oncology Service, Durham VA Medical Center, Durham, NC, USA.
  • Ackerson BG; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.
  • Oyekunle T; Deartment of Radiology, Duke University Medical Center, Durham, NC, USA.
  • Niedzwiecki D; Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA.
  • Fecci PE; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA.
  • Kirkpatrick JP; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA.
  • Floyd SR; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
J Neurooncol ; 167(1): 219-227, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38340295
ABSTRACT

PURPOSE:

During stereotactic radiosurgery (SRS) planning for brain metastases (BM), brain MRIs are reviewed to select appropriate targets based on radiographic characteristics. Some BM are difficult to detect and/or definitively identify and may go untreated initially, only to become apparent on future imaging. We hypothesized that in patients receiving multiple courses of SRS, reviewing the initial planning MRI would reveal early evidence of lesions that developed into metastases requiring SRS.

METHODS:

Patients undergoing two or more courses of SRS to BM within 6 months between 2016 and 2018 were included in this single-institution, retrospective study. Brain MRIs from the initial course were reviewed for lesions at the same location as subsequently treated metastases; if present, this lesion was classified as a "retrospectively identified metastasis" or RIM. RIMs were subcategorized as meeting or not meeting diagnostic imaging criteria for BM (+ DC or -DC, respectively).

RESULTS:

Among 683 patients undergoing 923 SRS courses, 98 patients met inclusion criteria. There were 115 repeat courses of SRS, with 345 treated metastases in the subsequent course, 128 of which were associated with RIMs found in a prior MRI. 58% of RIMs were + DC. 17 (15%) of subsequent courses consisted solely of metastases associated with + DC RIMs.

CONCLUSION:

Radiographic evidence of brain metastases requiring future treatment was occasionally present on brain MRIs from prior SRS treatments. Most RIMs were + DC, and some subsequent SRS courses treated only + DC RIMs. These findings suggest enhanced BM detection might enable earlier treatment and reduce the need for additional SRS.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Radiocirurgia Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Radiocirurgia Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article